| Product Code: ETC11766405 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Coronary Heart Disease Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Coronary Heart Disease Market Revenues & Volume, 2021 & 2031F |
3.3 China Coronary Heart Disease Market - Industry Life Cycle |
3.4 China Coronary Heart Disease Market - Porter's Five Forces |
3.5 China Coronary Heart Disease Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 China Coronary Heart Disease Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 China Coronary Heart Disease Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 China Coronary Heart Disease Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 China Coronary Heart Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Coronary Heart Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of risk factors such as obesity, hypertension, and diabetes in China |
4.2.2 Rising aging population leading to higher incidence of coronary heart disease |
4.2.3 Technological advancements in diagnostic tools and treatment options |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in rural areas of China |
4.3.2 High cost of coronary heart disease treatments and medications |
4.3.3 Lack of awareness about preventive measures and early detection of coronary heart disease |
5 China Coronary Heart Disease Market Trends |
6 China Coronary Heart Disease Market, By Types |
6.1 China Coronary Heart Disease Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 China Coronary Heart Disease Market Revenues & Volume, By Disease Type, 2021 - 2031F |
6.1.3 China Coronary Heart Disease Market Revenues & Volume, By Stable Angina, 2021 - 2031F |
6.1.4 China Coronary Heart Disease Market Revenues & Volume, By Unstable Angina, 2021 - 2031F |
6.1.5 China Coronary Heart Disease Market Revenues & Volume, By Myocardial Infarction, 2021 - 2031F |
6.1.6 China Coronary Heart Disease Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 China Coronary Heart Disease Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 China Coronary Heart Disease Market Revenues & Volume, By Medication, 2021 - 2031F |
6.2.3 China Coronary Heart Disease Market Revenues & Volume, By Surgery, 2021 - 2031F |
6.2.4 China Coronary Heart Disease Market Revenues & Volume, By Lifestyle Management, 2021 - 2031F |
6.2.5 China Coronary Heart Disease Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 China Coronary Heart Disease Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 China Coronary Heart Disease Market Revenues & Volume, By Beta Blockers, 2021 - 2031F |
6.3.3 China Coronary Heart Disease Market Revenues & Volume, By Statins, 2021 - 2031F |
6.3.4 China Coronary Heart Disease Market Revenues & Volume, By Aspirin, 2021 - 2031F |
6.3.5 China Coronary Heart Disease Market Revenues & Volume, By Others, 2021 - 2031F |
6.4 China Coronary Heart Disease Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 China Coronary Heart Disease Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 China Coronary Heart Disease Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4.4 China Coronary Heart Disease Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.5 China Coronary Heart Disease Market Revenues & Volume, By Others, 2021 - 2031F |
6.5 China Coronary Heart Disease Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 China Coronary Heart Disease Market Revenues & Volume, By Direct Sales, 2021 - 2031F |
6.5.3 China Coronary Heart Disease Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.5.4 China Coronary Heart Disease Market Revenues & Volume, By Distributors, 2021 - 2031F |
6.5.5 China Coronary Heart Disease Market Revenues & Volume, By Others, 2021 - 2031F |
7 China Coronary Heart Disease Market Import-Export Trade Statistics |
7.1 China Coronary Heart Disease Market Export to Major Countries |
7.2 China Coronary Heart Disease Market Imports from Major Countries |
8 China Coronary Heart Disease Market Key Performance Indicators |
8.1 Average wait time for coronary heart disease diagnosis and treatment |
8.2 Adoption rate of new technologies in the diagnosis and treatment of coronary heart disease |
8.3 Percentage of population undergoing regular screenings for risk factors such as high cholesterol and blood pressure |
9 China Coronary Heart Disease Market - Opportunity Assessment |
9.1 China Coronary Heart Disease Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 China Coronary Heart Disease Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 China Coronary Heart Disease Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 China Coronary Heart Disease Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 China Coronary Heart Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Coronary Heart Disease Market - Competitive Landscape |
10.1 China Coronary Heart Disease Market Revenue Share, By Companies, 2024 |
10.2 China Coronary Heart Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here